Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA7 | P43166 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.44 |
| ▸ | MYC | P01106 | 2/20 | 0.44 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.42 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | CDC25B | P30305 | 1/20 | 0.41 |
| ▸ | LDHA | P00338 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2749203 | 0.82 | PTPN1 (0.59) | ALDH1A1PTPN1MYCTDP1MEN1 | |
| SCHEMBL3391531 | 0.81 | LDHA (0.61) | CA12CA1CA2CA7CA9 | |
| SCHEMBL8153524 | 0.81 | KMT2A (0.46) | ALDH1A1ESR1ESR2HSD17B10TDP1 | |
| SCHEMBL2354671 | 0.81 | RXFP1 (0.51) | ALDH1A1MYCTDP1MEN1MAPT | |
| SCHEMBL2187409 | 0.80 | CA12 (0.52) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9274158 | 0.79 | CA12 (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9622910 | 0.79 | CA12 (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL4124483 | 0.79 | TSHR (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL23909563 | 0.78 | PTPN1 (0.46) | ALDH1A1PTPN1MYCLCKCDC25B | |
| SCHEMBL2128646 | 0.78 | CA12 (0.46) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113748021-A | Method for producing liquid crystal polyester processed product | 本州化学工业株式会社 | 2021-12-03 | — | — | CN | disclosed |
| EP-1983020-B1 | METHOD FOR MODIFICATION OF LIQUID CRYSTAL POLYMER | LEF TECHNOLOGY INC (JP) | 2014-05-07 | — | — | EP | disclosed |
| US-7608371-B2 | Irradiating polyesters with laser beam having pulse width of 10-12 seconds or less to improve physical strength; abrasion resistance | LEF TECHNOLOGY, INC. (JP) | 2009-10-27 | — | — | US | disclosed |
| US-20090048362-A1 | Method of Modifying Liquid Crystal Polymers | LEF TECHNOLOGY, INC. (JP) | 2009-02-19 | — | — | US | disclosed |
| EP-1983020-A1 | METHOD FOR MODIFICATION OF LIQUID CRYSTAL POLYMER | LEF Technology Inc. (JP) | 2008-10-22 | — | — | EP | disclosed |
| EP-1549598-A4 | NAPTHTHALENE DERIVATIVES WHICH INHIBIT THE CYTOKINE OR BIOLOGICAL ACTIVITY OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) | CORTICAL PTY LTD (AU) | 2008-01-23 | — | — | EP | disclosed |
| US-20060106102-A1 | Napththalene derivatives which inhibit the cytokine or biological activity of microphage migration inhibitory factor (mif) | Morand, Eric | 2006-05-18 | — | — | US | disclosed |
| EP-1549598-A1 | NAPTHTHALENE DERIVATIVES WHICH INHIBIT THE CYTOKINE OR BIOLOGICAL ACTIVITY OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) | Cortical Pty Ltd (AU) | 2005-07-06 | — | — | EP | disclosed |
| WO-2003104178-A1 | NAPTHTHALENE DERIVATIVES WHICH INHIBIT THE CYTOKINE OR BIOLOGICAL ACTIVITY OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) | CORTICAL PTY LTD (AU) | 2003-12-18 | — | — | WO | disclosed |
| US-6656386-B2 | To provide molded article having reflow- soldering heat resistance | KABUSHIKI KAISHA UENO SEIYAKU OYO KENKUJO (JP) | 2003-12-02 | — | — | US | disclosed |
| US-20030008979-A1 | Wholly aromatic heat-stable liquid crystalline polyester resin composition with improved melt flowability | KABUSHIKI KAISHA UENO SEIYAKU OYO K. | 2003-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060106102-A1 | Napththalene derivatives which inhibit the cytokine or biological activity of microphage migration inhibitory factor (mif) | MIF, ARG1, MSR1 | CA12 1448/4885CA1 2883/4885CA2 3698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.